132 related articles for article (PubMed ID: 31318093)
1. Design, synthesis and biological evaluation of peptide-NSAID conjugates for targeted cancer therapy.
Shokri B; Zarghi A; Shahhoseini S; Mohammadi R; Kobarfard F
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800379. PubMed ID: 31318093
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy.
Shokri B; Zarghi A; Shahhoseini S; Mohammadi R; Kobarfard F
Iran J Pharm Res; 2018; 17(4):1297-1305. PubMed ID: 30568688
[TBL] [Abstract][Full Text] [Related]
3. NGR-peptide-drug conjugates with dual targeting properties.
Enyedi KN; Tóth S; Szakács G; Mező G
PLoS One; 2017; 12(6):e0178632. PubMed ID: 28575020
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
[TBL] [Abstract][Full Text] [Related]
5. Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature.
Mukhopadhyay S; Barnés CM; Haskel A; Short SM; Barnes KR; Lippard SJ
Bioconjug Chem; 2008 Jan; 19(1):39-49. PubMed ID: 17845003
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
[TBL] [Abstract][Full Text] [Related]
7. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides.
Zamora A; Gandioso A; Massaguer A; Buenestado S; Calvis C; Hernández JL; Mitjans F; Rodríguez V; Ruiz J; Marchán V
ChemMedChem; 2018 Sep; 13(17):1755-1762. PubMed ID: 29932312
[TBL] [Abstract][Full Text] [Related]
8. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
[TBL] [Abstract][Full Text] [Related]
9. Curcumin Conjugates of Non-steroidal Anti-Inflammatory Drugs: Synthesis, Structures, Anti-proliferative Assays, Computational Docking, and Inflammatory Response.
Laali KK; Zwarycz AT; Beck N; Borosky GL; Nukaya M; Kennedy GD
ChemistryOpen; 2020 Aug; 9(8):822-834. PubMed ID: 32802728
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
Chen X; Plasencia C; Hou Y; Neamati N
J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G
Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of open-resorcinarene conjugates.
Daniel Pedro-Hernández L; Hernández-Montalbán C; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Bioorg Med Chem Lett; 2020 Jul; 30(14):127275. PubMed ID: 32527536
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity.
Krishnamoorthy R; Singh M; Anaikutti P; Paul L E; Dhanasekaran S; Sathiah T
Bioorg Chem; 2023 May; 134():106434. PubMed ID: 36863075
[TBL] [Abstract][Full Text] [Related]
20. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
